Mevo, a leading digital prescription platform in Brazil, has announced a significant milestone in its journey towards transforming the healthcare landscape in the country.
Revolutionizing Healthcare in Brazil
Mevo's latest Series B funding round of $19 million, led by Matrix, aims to bring a modern experience to customers by scaling digital prescriptions in Brazil. The funding will enable Mevo to expand its network of healthcare provider partners, enhance its digital prescription and pharmacy marketplace platform, and explore additional healthcare services beyond the fulfillment of prescriptions.
Funding for Growth and Innovation
With this substantial investment, Mevo plans to continue improving the customer experience and offering Brazilians a better way to access healthcare. Pedro Dias, CEO and co-founder of Mevo, expressed his excitement about the future of the company and its potential to revolutionize the healthcare industry in Brazil.
Empowering Patients and Healthcare Professionals
Mevo's innovative technology allows patients to easily access their prescriptions and purchase medications through a user-friendly mobile interface. By enabling healthcare providers to issue digital prescriptions, Mevo is modernizing the way people access prescriptions in Brazil. The platform's flexibility and ease of use are designed to improve patient experience and medication adherence, while also reducing bureaucratic processes and errors for healthcare professionals.
Vision for the Future
Mevo was founded in 2017 with the vision of becoming the infrastructure for e-prescriptions in Brazil, addressing the critical need for modernization and digitization in the healthcare sector. The company aims to simplify and improve the experience for patients, healthcare professionals, and healthcare providers by providing innovative solutions that enhance patient care and streamline healthcare processes.
Transforming Healthcare with Matrix
Matrix Partners, an early-stage venture capital firm, has shown its confidence in Mevo's vision and potential for growth. With a focus on investing in companies with deep technical expertise and a specific vision for the future, Matrix is proud to support Mevo in its mission to revolutionize digital prescriptions in Brazil.
Conclusion
Mevo's Series B funding marks a significant milestone in the company's journey towards transforming the healthcare industry in Brazil. With a focus on innovation, customer experience, and industry disruption, Mevo is poised to lead the way in modernizing healthcare in the country.